Financhill
Sell
34

ALEC Quote, Financials, Valuation and Earnings

Last price:
$1.22
Seasonality move :
23.13%
Day range:
$1.11 - $1.25
52-week range:
$0.87 - $3.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.76x
P/B ratio:
2.29x
Volume:
2.8M
Avg. volume:
2.5M
1-year change:
-44.75%
Market cap:
$132.1M
Revenue:
$100.6M
EPS (TTM):
-$1.07

Analysts' Opinion

  • Consensus Rating
    Alector, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $2.05, Alector, Inc. has an estimated upside of 69.42% from its current price of $1.21.
  • Price Target Downside
    According to analysts, the lowest downside price target is $0.75 representing 100% downside risk from its current price of $1.21.

Fair Value

  • According to the consensus of 8 analysts, Alector, Inc. has 69.42% upside to fair value with a price target of $2.05 per share.

ALEC vs. S&P 500

  • Over the past 5 trading days, Alector, Inc. has underperformed the S&P 500 by -10.48% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Alector, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Alector, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Alector, Inc. reported revenues of $3.3M.

Earnings Growth

  • Alector, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Alector, Inc. reported earnings per share of -$0.34.
Enterprise value:
-121.2M
EV / Invested capital:
-1.27x
Price / LTM sales:
1.76x
EV / EBIT:
--
EV / Revenue:
-1.75x
PEG ratio (5yr expected):
-1.71x
EV / Free cash flow:
0.61x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$59.6M
Return On Assets:
-25.84%
Net Income Margin (TTM):
-156.03%
Return On Equity:
-114.8%
Return On Invested Capital:
-81.03%
Operating Margin:
-1156.69%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $96.3M $61.5M $69M $15.3M $3.3M
Gross Profit $87.6M $52.5M $59.6M $13.2M $928K
Operating Income -$159.7M -$185.2M -$121.6M -$48.4M -$37.7M
EBITDA -$151M -$176.2M -$112.1M -$46.2M -$35.4M
Diluted EPS -$1.70 -$1.71 -$1.07 -$0.43 -$0.34
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $788M $775M $613.1M $469.4M $300.4M
Total Assets $854.2M $837M $672.4M $516M $335.3M
Current Liabilities $132.8M $160.9M $155.4M $142.5M $80M
Total Liabilities $518.3M $583.9M $509.8M $397.1M $277.6M
Total Equity $335.9M $253.1M $162.6M $118.9M $57.7M
Total Debt $48.6M $36.5M $31.8M $26M $28.9M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$187M -$220.9M -$197.4M -$50.7M -$32.5M
Cash From Investing $102.2M $83.8M $212.4M $40.3M $49.5M
Cash From Financing $2.6M $72.3M $24.6M -- $14.7M
Free Cash Flow -$189.9M -$222.3M -$197.6M -$50.9M -$32.5M
ALEC
Sector
Market Cap
$132.1M
$28.8M
Price % of 52-Week High
35.59%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
-4.73%
-1.32%
1-Year Price Total Return
-44.75%
-20.64%
Beta (5-Year)
0.667
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $1.25
200-day SMA
Sell
Level $1.74
Bollinger Bands (100)
Sell
Level 1.4 - 2.88
Chaikin Money Flow
Sell
Level -36.2M
20-day SMA
Sell
Level $1.26
Relative Strength Index (RSI14)
Sell
Level 35.98
ADX Line
Sell
Level 36.91
Williams %R
Neutral
Level -60
50-day SMA
Sell
Level $2.01
MACD (12, 26)
Sell
Level -0.19
25-day Aroon Oscillator
Sell
Level -92
On Balance Volume
Neutral
Level 16.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-2.173)
Sell
CA Score (Annual)
Level (-2.7709)
Buy
Beneish M-Score (Annual)
Level (-2.3644)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (2.6178)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Stock Forecast FAQ

In the current month, ALEC has received 1 Buy ratings 6 Hold ratings, and 1 Sell ratings. The ALEC average analyst price target in the past 3 months is $2.05.

  • Where Will Alector, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Alector, Inc. share price will rise to $2.05 per share over the next 12 months.

  • What Do Analysts Say About Alector, Inc.?

    Analysts are divided on their view about Alector, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Alector, Inc. is a Sell and believe this share price will drop from its current level to $0.75.

  • What Is Alector, Inc.'s Price Target?

    The price target for Alector, Inc. over the next 1-year time period is forecast to be $2.05 according to 8 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is ALEC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Alector, Inc. is a Hold. 6 of 8 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of ALEC?

    You can purchase shares of Alector, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Alector, Inc. shares.

  • What Is The Alector, Inc. Share Price Today?

    Alector, Inc. was last trading at $1.22 per share. This represents the most recent stock quote for Alector, Inc.. Yesterday, Alector, Inc. closed at $1.21 per share.

  • How To Buy Alector, Inc. Stock Online?

    In order to purchase Alector, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 190.82% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 0.06% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 1.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock